Atara Biotherapeutics
ATRA
$11.99
Share price
3.93%
Change (1 day)
-56.42%
Change (1 year)
Categories
Revenue for Atara Biotherapeutics (ATRA)
Revenue in 2024 (TTM): NZ$0.21 Billion
According to Atara Biotherapeutics's latest financial reports the company's current revenue (TTM 
) is NZ$0.22 Billion. an increase over the revenue in the year 2023 that were of NZ$13.55 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Atara Biotherapeutics from 2013 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | NZ$0.22 B | 1586.51% |
| 2023 | NZ$13.55 M | -86.46% |
| 2022 | NZ$0.10 B | 236.25% |
| 2021 | NZ$29.77 M | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | NZ$0.27 B | 24.42% | 🇺🇸 USA |
 | NZ$1.67 M | -99.25% | 🇩🇪 Germany |
 | NZ$0.50 B | 123.06% | 🇺🇸 USA |